Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-surgical and obstructive gastroparesis.

Mehnaz A Shafi1, P Jay Pasricha

  • 1University of Texas Medical Branch, 4.106 McCullough Building, 301 University Boulevard, Galveston TX 77555-0764, USA.

Current Gastroenterology Reports
|September 22, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of current therapeutic strategies for immune checkpoint inhibitor-related esophagitis.

Annals of gastroenterology·2026
Same author

Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy.

Therapeutic advances in medical oncology·2026
Same author

Master of innovation: unlocking creativity in the development of novel solutions from interventional endoscopy to neurogastroenterology.

iGIE : innovation, investigation and insights·2026
Same author

Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis from Cancer Immunotherapy.

Targeted oncology·2025
Same author

<i>Helicobacter pylori</i> infection negatively affects response of gastric cancer to immunotherapy.

Annals of gastroenterology·2025
Same author

The Effect of Immune Checkpoint Inhibitor Therapy on Pre-Existing Gastroparesis and New Onset of Symptoms of Delayed Gastric Emptying.

Cancers·2024

Post-surgical gastroparesis (PSG) can occur after abdominal surgery due to vagal nerve injury. While many cases resolve with time, persistent symptoms require a multidisciplinary approach and may benefit from gastric electrical stimulation.

Area of Science:

  • Gastroenterology
  • Surgical Complications
  • Neurology

Background:

  • Post-surgical gastroparesis (PSG) is a recognized complication following upper abdominal surgery, often linked to vagal nerve injury.
  • Historically associated with vagotomy for peptic ulcer disease, PSG is increasingly diagnosed after procedures for GERD, morbid obesity, and organ transplantation.
  • Potential causes include direct vagal nerve damage, opportunistic infections, and drug effects in transplant patients.

Purpose of the Study:

  • To review the causes, presentation, and management strategies for post-surgical gastroparesis.
  • To highlight the evolving landscape of PSG with advancements in surgical interventions.
  • To discuss conservative and advanced treatment options for persistent symptoms.

Main Methods:

Related Experiment Videos

  • Literature review of post-surgical gastroparesis.
  • Analysis of clinical presentations and outcomes.
  • Evaluation of management strategies, including conservative care and interventions.

    • Main Results:

    • Many PSG symptoms resolve spontaneously post-operatively, attributed to enteric nervous system adaptation or vagal reinnervation.
    • Persistent symptoms present significant management challenges, necessitating a multidisciplinary team approach.
    • Gastric electrical stimulation shows preliminary promise for refractory cases.

    Conclusions:

    • Post-surgical gastroparesis is a complex condition with varied etiologies and presentations.
    • Conservative management is the initial approach, with a multidisciplinary strategy for persistent cases.
    • Emerging therapies like gastric electrical stimulation warrant further investigation.